http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3190898-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0543466e38a47c03255b235098c0b9c9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23D9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-15
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23D9-007
filingDate 2015-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f75387da85d2cd0033ab3906cdacd9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eba096374db999a12a83e126527462c5
publicationDate 2017-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3190898-A1
titleOfInvention Ubidecarenone composition
abstract The present invention relates to a new composition comprising ubidecarenone with improved bioavailability for use in softgel capsules. The compositions can be used as a medicine, a food or food supplement. The invention further relates to compositions comprising different fats or oils that facilitate the manufacture and stability of crystallized ubidecarenone.
priorityDate 2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226489190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57501260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359

Total number of triples: 24.